Reta glucagon-like peptide-1 (GLP-1) receptor agonists represent a groundbreaking method to diabetes management. These innovative drugs function by mimicking the physiological actions of GLP-1, a hormone secreted by the gut in here response to meals. By activating GLP-1 receptors in the pancreas, these agents enhance insulin secretion and suppress

The management of diabetes is with the emergence of exciting new therapies. Among these, Reta, GLP-1 receptor agonists, Retatrutide, and Trizepatide are gaining significant recognition. These medications offer promising strategies for controlling blood sugar levels and could improve the lives of individuals living with diabetes. This novel class